GeoVax Labs, Inc.
GOVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000832489
No open-market purchases or sales by GeoVax Labs, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $625.5K in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in GeoVax Labs, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +1 vs. Q4 2021
- Shares held
- 946.8K
- +483.2K (+104.2%) vs. Q4 2021
- Total value
- $1.09M
- −$591.0K (−35.2%) vs. Q4 2021
- New holders
- 6
- 2 more added
- Sold out
- 5
- 3 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $625.5K |
| Q1 2026 | 16 | $459.6K |
| Q4 2025 | 22 | $468.7K |
| Q3 2025 | 21 | $919.3K |
| Q2 2025 | 21 | $478.3K |
| Q1 2025 | 18 | $1.24M |
| Q4 2024 | 19 | $715.6K |
| Q3 2024 | 17 | $1.08M |
| Q2 2024 | 12 | $619.1K |
| Q1 2024 | 11 | $481.2K |
| Q4 2023 | 16 | $1.13M |
| Q3 2023 | 14 | $797.6K |
| Q2 2023 | 16 | $886.0K |
| Q1 2023 | 17 | $1.07M |
| Q4 2022 | 20 | $1.35M |
| Q3 2022 | 23 | $3.39M |
| Q2 2022 | 19 | $2.02M |
| Q1 2022 | 16 | $1.09M |
| Q4 2021 | 15 | $1.68M |
| Q3 2021 | 13 | $1.98M |
| Q2 2021 | 10 | $1.99M |
| Q1 2021 | 10 | $1.22M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding GeoVax Labs, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stephens Consulting, LLC | 500 | $575 | 0.00% | −500−50.0% | Reduced |
| Wells Fargo & Company | 2,044 | $2.00K | 0.00% | +5+0.2% | Added |
| Citigroup Inc | 3,500 | $4.00K | 0.00% | +3,500 | New |
| Morgan Stanley | 4,980 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,836 | $7.00K | 0.00% | +5,836 | New |
| Northern Trust Corp | 11,564 | $13.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 14,930 | $17.0K | 0.00% | −702−4.5% | Reduced |
| Citadel Advisors LLC | 16,457 | $19.0K | 0.00% | +16,457 | New |
| Welch & Forbes LLC | 16,994 | $20.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 22,142 | $25.0K | 0.00% | +442+2.0% | Added |
| Dimensional Fund Advisors LP | 24,062 | $28.0K | 0.00% | −3,526−12.8% | Reduced |
| Two Sigma Investments, LP | 27,323 | $31.0K | 0.00% | +27,323 | New |
| Virtu Financial LLC | 49,684 | $57.0K | 0.00% | +49,684 | New |
| Geode Capital Management, LLC | 52,824 | $60.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 258,766 | $298.0K | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 435,150 | $500.0K | 0.01% | +435,150 | New |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −34,497−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,497−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,502−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |